US Stock MarketDetailed Quotes
CDXC ChromaDex
- 3.380
- -0.090-2.59%
Close Oct 4 16:00 ET
- 3.410
- +0.030+0.89%
Post 20:02 ET
256.65MMarket Cap-112666P/E (TTM)
3.535High3.380Low167.90KVolume3.510Open3.470Pre Close579.05KTurnover0.34%Turnover RatioLossP/E (Static)75.93MShares4.65052wk High8.35P/B164.84MFloat Cap1.25052wk Low--Dividend TTM48.77MShs Float23.660Historical High--Div YieldTTM4.47%Amplitude0.052Historical Low3.448Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
ChromaDex Stock Forum
ChromaDex Announces Expansion of Pharmaceutical-Grade Niagen® IV and Injection Offerings to Additional Leading Wellness Clinics
ChromaDex Corp. (NASDAQ:CDXC) has announced the expansion of its pharmaceutical-grade Niagen® (nicotinamide riboside chloride) IV and injection offerings to 14 additional leading wellness clinics across the United States. This follows the successful debut of quantities in select clinics last month. Wells Pharma of Houston, a U.S. FDA-registered ...
ChromaDex Secures U.S. Patent for the Composition of Matter of Salt Forms of NMNH (Dihydronicotinamide Mononucleotide), a Precursor to NAD+
ChromaDex Corp. (NASDAQ:CDXC) has secured U.S. Patent number 10,000,520 C1 for the composition of matter of salt forms of NMNH (dihydronicotinamide mononucleotide), a precursor to NAD+. This patent, co-owned with Queen's University Belfast, grants ChromaDex exclusive rights to the disodium salt form of NMNH. The company now has over ...
ChromaDex Announces Pharmaceutical-Grade Intravenous and Injectable Niagen® Will Debut at Leading Wellness Clinics in August
ChromaDex Corp. (NASDAQ:CDXC) announces the debut of pharmaceutical-grade Niagen® (nicotinamide riboside chloride) for intravenous and injectable use at leading wellness clinics in August. Wells Pharma of Houston, a U.S. FDA-registered 503B outsourcing facility, will compound and distribute Niagen+ to select IV clinics.
Niagen IV offers superior t...
NEWS
ChromaDex’s NIAGEN® (Patented Nicotinamide Riboside, NR), the Most Efficient and High-Quality NAD+ Precursor, Featured in New Solgar® Cellular Nutrition Cellular Energy Supplement
Go go CDXC! 🥳
Nice! Li kaishing very own elixir biomedical company .
$BABA-W (09988.HK)$ $UOB (U11.SG)$ $CapLand Ascott Trust (HMN.SG)$ $Sembcorp Ind (U96.SG)$ $Yum China (YUMC.US)$ $IFAST (AIY.SG)$ $CKI FIN B2412 (05060.HK)$
No comment yet